Day TwoWednesday, 17 May 2023 - EST (Eastern Standard Time, GMT-5)

7:15am - 8:15am60 mins

Conference Registration and Networking Breakfast

8:15am - 8:30am15 mins

Conference Director Welcome

8:30am - 8:45am15 mins

Co-Chair Welcome and Opening Remarks

8:45am - 9:25am40 mins

Opening Keynote: Analysis and Perspective on the Current State of Drug Policy and Pricing

9:25am - 10:00am35 mins

Updated Review and Interpretation of the Inflation Reduction Act

James Manser - Executive Director, Government & External Affairs, Endo Pharmaceuticals

10:00am - 10:45am45 mins

Panel: The Effects of the Inflation Reduction Act Across Commercial and Government Pricing

Jesse Mendelsohn - Senior Vice President, Model N
Mallory O’Connor - Executive Director, Public Policy, Mallinckrodt Pharmaceuticals
Funso Olufade, PhD, MBA - Sr. Director – Head, Commercial Finance, Ascendis Pharma
Leonard Fairfield - Contract Operations & Analytics Director, Actelion
Erika George - Pricing & Trade Director, Contracts, Neurocrine Biosciences

10:45am - 11:15am30 mins

Morning Networking Refreshment Break

11:15am - 11:45am30 mins

Update: CMS Guidance on the Inflation Reduction Act and Implementation

11:45am - 12:25pm40 mins

Implications of Stacked and Value Based Contract Product Agreements on Best Price and Medicaid Pricing

Chris Weiser - Corporate Counsel, US Market Access Legal, Sanofi
Ashley Bender Spirn - Senior Counsel, U.S. Pricing and Access, Gilead Sciences

12:25pm - 1:30pm65 mins

Networking Luncheon

1:30pm - 2:15pm45 mins

Panel: Comparing Challenges Based on Company Size and Type and Operationalizing SOPs

2:15pm - 2:45pm30 mins

The Enforcement and Penalties Landscape Within State Drug Pricing Reporting

2:45pm - 3:15pm30 mins

Afternoon Networking Refreshment Break

3:15pm - 3:45pm30 mins

Increase in Discount Pressure from Consolidated Payers Based on PBM Fees

3:45pm - 4:15pm30 mins

Executive Order on Innovative Payment Models

4:15pm - 4:30pm15 mins

Co-Chairs Closing Remarks